Materialise: Medical Segment Continues To Thrive
While Materialise's (NASDAQ: MTLS ) Q1 results were a mixed bag, they were well received by investors due to extremely low expectations. The Medical segment continues to grow at a healthy pace, and Materialise's guidance suggests that tariffs will be lessRichard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena believes that excess risk adjusted returns can be achieved by identif ...